13F HOLDINGS REPORT
ISZO CAPITAL MANAGEMENT LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001013594-23-000495
Total Value
$18.8M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LANTHEUS HLDGS INC | LNTH | 100,000 | $8.3M | 43.89% |
| 2 | CBL & ASSOC PPTYS INC | 012430878 | 82,081 | $2.1M | 11.19% |
| 3 | NOVARTIS AG | NVSEF | 22,000 | $2.0M | 10.76% |
| 4 | UNITED THERAPEUTICS CORP DEL | UTHR | 9,000 | $2.0M | 10.71% |
| 5 | INVESCO QQQ TR | IVZ | 4,800 | $1.5M | 8.19% |
| 6 | NOVO-NORDISK A S | NONOF | 7,000 | $1.1M | 5.92% |
| 7 | SPDR S&P 500 ETF TR | SPY | 2,500 | $1.0M | 5.44% |
| 8 | FIRST REP BK SAN FRANCISCO C | 33616C100 | 52,000 | $727,480 | 3.87% |
| 9 | AMPLIFY ENERGY CORP NEW | AMPY | 953 | $6,547 | 0.03% |
| 10 | GLOBAL CORD BLOOD CORPORATIO | G39342103 | 279,495 | $0 | 0.00% |